SLRN

ALMS

This biopharmaceutical company develops oral therapies to treat patients with immune-mediated diseases, neuroinflammatory conditions and neurodegenerative disorders.

Clinical-stage biotech

This company develops immunomodulatory recombinant protein therapies to treat autoimmune and chronic inflammatory diseases for patients with conditions such as chronic inflammatory demyelinating polyneuropathy.

Acelyrin, Inc

This biopharmaceutical company develops protein therapeutics and monoclonal antibodies to treat inflammatory diseases for patients with unmet medical needs.

Beeline Medicines

This clinical-stage biotechnology company develops precision therapies for patients living with autoimmune and inflammatory diseases.

Calliditas therapeutics

This biopharmaceutical company develops and commercialises medicines for patients with rare renal and hepatic diseases.

Ultragenyx

This biopharmaceutical company develops and commercialises therapies for patients with serious rare and ultra-rare genetic diseases.

Zenas

This biopharmaceutical company develops and commercialises immunology-based therapies for patients with autoimmune diseases and rare fibroinflammatory conditions.

VTYX

This biopharmaceutical company develops oral small-molecule medicines for patients with autoimmune, inflammatory, cardiovascular and neurodegenerative diseases.